Nautilus Biotechnology Inc (NAUT) is a Healthcare · Biotechnology company listed on NASDAQ. Price $0.98 (+0.36%), Market cap $0.30B, 52-week low–high $0.64 ~ $3.95.
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. The company develops Nautilus Voyager Platform, which includes an end-to-end solution comprising instruments, reagents, consumables, and software analysis. It also provides nautilus voyager instrument, a high-resolution optical imaging system with integrated fluidics and liquid handling sub-system to deposit protein libraries onto a flow cell and to process labeled multi-affinity reagent binding and imaging cycles rapidly to decode and quantify the proteins present in biological samples. In additi
Financial statements, price targets, institutional (13F) holdings and related news for Nautilus Biotechnology Inc are updated in real time on BlackAll Trade.
Nautilus Biotechnology Inc trades at $0.98 (+0.36%). Real-time quotes and charts are available on BlackAll Trade.
Nautilus Biotechnology Inc has a market cap of about $0.30B.
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States. Th